Bisphosphonate Treatment of Bone Fibrous Dysplasia in McCune-Albright Syndrome

Journal of Pediatric Endocrinology and Metabolism

Volumn 19, Issue , 2006, Pages 583-594

  Lala, Roberto ^a   Matarazzo, Patrizia ^a   Andreo, Maria ^a   Marzari, Daniela ^a   Bellone, Jaele ^a   Corrias, Andrea ^a   de Sanctis, Carlo ^a  

^a REGINA MARGHERITA CHILDREN S HOSPITAL   (Italy)

Author keywords

bisphosphonate treatment; bone fibrous dysplasia; McCune Albright syndrome

Indexed keywords

ALKALINE PHOSPHATASE; ANALGESIC AGENT; ANTIPYRETIC AGENT; AROMATASE INHIBITOR; BISPHOSPHONIC ACID DERIVATIVE; CALCITRIOL; CALCIUM; OCTREOTIDE; PAMIDRONIC ACID; PHOSPHATE;

ADOLESCENT; ADULT; ALBRIGHT SYNDROME; ARTICLE; BONE LESION; BONE MALFORMATION; BONE PAIN; BONE TURNOVER; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FEVER; FIBROUS DYSPLASIA; FOLLOW UP; FRACTURE; GAIT DISORDER; GROUPS BY AGE; HEALING; HEARING IMPAIRMENT; HUMAN; HYPERPYREXIA; HYPOCALCEMIA; LIMB DEFORMITY; LONG BONE; LONG TERM CARE; MALE; METAPHYSIS; PHLEBITIS; RADIODIAGNOSIS; RISK REDUCTION; SEX DIFFERENCE; SKULL MALFORMATION; STOMACH PAIN; VISUAL IMPAIRMENT;

ADOLESCENT; ALKALINE PHOSPHATASE; BONE DENSITY CONSERVATION AGENTS; CHILD; CHILD, PRESCHOOL; DIPHOSPHONATES; FEMALE; FIBROUS DYSPLASIA, POLYOSTOTIC; FOLLOW-UP STUDIES; FRACTURES, SPONTANEOUS; HUMANS; MALE; PAIN; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 33745270592     PISSN: 0334018X     EISSN: 21910251     Source Type: Journal    
DOI: 10.1515/JPEM.2006.19.S2.583     Document Type: Article

References (25)

1. McCune DJ, Bruch H. Osteodystrophia fibrosa: report of a case in which the condition was combined with precocious puberty, pathologic pigmentation of the skin and hyperthyroidism, with a review of the literature. Am J Dis Child 1937; 54: 806-848.
2. Schoenau E, Rauch F. Fibrous dysplasia. Horm Res 2002; 57: 79-82.
3. Riminucci M, Liu B, Corsi A, Shenker A, Spiegel AM, Gehron Robey P, Bianco P. The histopathology of fibrous displasia of bone in patients with activating mutations of the Gsalpha gene: site-specific patterns and recurrent histological hallmarks. J Pathol 1999; 137: 249-258.
4. Yamamoto T, Ozono K, Kasayama S, Joh K, Hiroshima K, Takagi M, Matsumoto S, Michigami T, Yamaoka K, Kishimoto T, Okada S. Increased IL-6 production by cells isolated from the fibrous bone dysplasia tissues in patients with McCune-Albright syndrome. J Clin Invest 1996; 98: 30-35.
5. Liens B, Delmas PD, Meunier PJ. Long-term effects of intravenous Pamidronate in fibrous dysplasia of bone. Lancet 1994; 343: 953-954.
6. Chapurlat R, Delmas PD, Liens D, Meunier PJ. Long-term effects of intravenous pamidronate in fibrous dysplasia of bone. J Bone Miner Res 1997; 12: 1746-1752.
7. Zacharin M, O'Sullivan M. Intravenous pamidronate treatment of polyostotic fibrous dysplasia associated with the McCune-Albright syndrome. J Pediatr 2000; 137: 403-409.
8. Isaia GC, Lala R, Defilippi C, Matarazzo P, Andreo M, Roggia C, Priolo G, de Sanctis C. Bone turnover in children and adolescents with McCune-Albright syndrome treated with pamidronate for bone fibrous dysplasia. Calcif Tissue Int 2002; 71: 121-128.
9. Matarazzo P, Lala R, Masi G, Andreo M, Altare F, de Sanctis C. Pamidronate treatment in bone fibrous dysplasia in children and adolescents with McCune-Albright syndrome. J Pediatr Endocrinol Metab 2002; 15 (Suppl 3): 929-937.
10. Plotkin H, Rauch F, Zeitlin L, Munns C, Travers R, Glorieux FH. Effect of pamidronate treatment in children with polyostotic fibrous displasia of bone. J Clin Endocrinol Metab 2003; 88: 4569-4575.
11. Chapurlat RD, Hugueny P, Delmas PD, Meunier PJ. Treatment of fibrous dysplasia of bone with intravenous pamidronate: long-term effectiveness and evaluation of predictors of response to treatment. Bone 2004; 35: 235-242.
12. Feuillan PP, Johns J, Cutler GB. Long-term testolactone therapy for precocious puberty in girls with the McCune-Albright syndrome. J Clin Endocrinol Metab 1993; 77: 647-651.
13. Tanner JM, Whitehouse RH, Takaishi M. Standards from birth to maturity for height, weight, height velocity, weight velocity: British children, 1965. Part II. Arch Dis Child 1966; 41: 613-635.
14. Grumbach MM. Estrogen, bone, growth and sex: a sea change in conventional wisdom. J Pediatr Endocrinol Metab 2000; 13: 1439-1455.
15. Di Candia S, Weber G, Mora S, de Pellegrin M, Chiumello G. Early fractures and occult hyperthyroidism: McCune-Albright syndrome? Horm Res 2001; 56: 58-62.
16. Chanson P, Dib A, Visot A, Derome PJ. McCune-Albright syndrome and acromegaly: clinical studies and response to treatment in five cases. Eur J Endocrinol 1994; 131: 229-234.
17. Lukert BP, Raisz LG. Glucorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med 1990; 112: 352-364.
18. Lala R, Matarazzo P, Andreo M, Defilippi C, de Sanctis C. Impact of endocrine hyperfunction and phosphate wasting on bone in McCune-Albright syndrome. J Pediatr Endocrinol Metab 2002; 15 (Suppl 3): 913-920.
19. Collins MT, Chebli C, Jones J, Kushner H, Consugar M, Rinaldo P, Wientroub S, Bianco P, Robey PG. Renal phosphate wasting in fibrous dysplasia of bone is a part of generalized renal tubular dysfunction similar to that seen in tumor-induced osteomalacia. J Bone Miner Res 2001; 16: 806-813.
20. Zung A, Chalew SA, Schwidinger WF, Levine MA, Phillip M, Jara A, Counts DR, Kowarski AA. Urinary cyclic 3′,5′-monophosphate response in McCune-Albright syndrome: cyclical evidence for altered renal adenylate cyclase activity. J Clin Endocrinol Metab 1995; 80: 3576-3581.
21. Riminucci M, Collins MT, Fedarko NS, Cherman N, Corsi A, White KE, Waguespack S, Gupta A, Hannon T, Econs MJ, Bianco P, Gehron Robey P. FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting. J Clin Invest. 2003; 112: 683-692.
22. Leet AI, Chebli C, Kushner H, Chen CC, Kelly MH, Brillante BA, Robey PG, Bianco P, Wientroub S, Collins MT. Fracture incidence in polyostotic fibrous dysplasia and the McCune-Albright syndrome. J Bone Miner Res 2004; 19: 571-577.
23. Kos M, Luczak K, Godzinski J, Klempous J. Treatment of monostotic fibrous dysplasia with pamidronate. J Craniomaxillofac Surg 2004; 32: 10-15.
24. Ippolito E, Bray EW, Corsi A, De Maio F, Exner UG, Robey PG, Grill F, Lala R, Massobrio M, Pinggera O, Riminucci M, Snela S, Zambakidis C, Bianco P; European Pediatric Orthopaedic Society. Natural history and treatment of fibrous dysplasia of bone: a multicenter clinicopathologic study promoted by the European Pediatric Orthopaedic Society. J Pediatr Orthop B 2003; 12: 155-177.
25. Ippolito E, Caterini R, Farsetti P, Potenza V. Surgical treatment of fibrous dysplasia of bone in McCune-Albright syndrome. J Pediatr Endocrinol Metab 2002; 15 (Suppl 3): 939-944.